Ajay Duseja (@ajay_duseja) 's Twitter Profile
Ajay Duseja

@ajay_duseja

Professor & Head of Hepatology, Secretary General, Indian National Association for Study of the Liver (INASL).
Tweets are personal.

ID: 1428383625993547786

calendar_today19-08-2021 15:50:15

1,1K Tweet

3,3K Followers

468 Following

Rohit Mehtani (@rohitmehtanidm) 's Twitter Profile Photo

Very pertinent topics.. covering day to day challenges we face in management of MASLD… Happy to be a part of this initiative by Ajay Duseja sir and INASL

Priya Jaisinghani, MD, DABOM (@drjayyy__) 's Twitter Profile Photo

We renamed a disease—not for science, but for people. 🩺 Proud to co-author the People-First Liver Charter alongside greats in Nature Portfolio 🔗 nature.com/articles/s4159… Words can heal. Let’s end stigma in MASLD/MASH—across every specialty. 🌍💬

We renamed a disease—not for science, but for people. 🩺

Proud to co-author the People-First Liver Charter alongside greats in <a href="/NaturePortfolio/">Nature Portfolio</a> 
🔗 nature.com/articles/s4159…

Words can heal. Let’s end stigma in MASLD/MASH—across every specialty. 🌍💬
Dr Nipun Verma (@drnipunverma) 's Twitter Profile Photo

Sunil Taneja INASL Ajay Duseja M PREMKUMAR Arka De Sahaj Rathi MD, DM, MRCP Rohit Mehtani Akash Roy EASLnews 🫀 Your liver works silently, but tirelessly. 🥦 Eat healthy 💤 Sleep well 🏃‍♂️ Move daily ✅ Fatty liver is preventable - let’s act now! #LiverHealth #PreventFattyLiver #EatMoveSleep 😊🌿 INASL

Joseph Sleiman, MD, FACP (@josephhabibi_md) 's Twitter Profile Photo

#CGH4ALL CGH 📣 🥚Nutrition isn’t just supportive care — it’s frontline therapy! 🍗High-protein, high-calorie diet 🍽️ improved survival, frailty & hospital stays in ALD-ACLF 🏥🫀 Find out more at 👇 🔗 doi.org/10.1016/j.cgh.… #Gitwitter #ALD #ACLF Reported by

#CGH4ALL <a href="/AGA_CGH/">CGH</a> 📣 

🥚Nutrition isn’t just supportive care — it’s frontline therapy!
🍗High-protein, high-calorie diet 🍽️ improved survival, frailty &amp; hospital stays in ALD-ACLF 🏥🫀

Find out more at 👇
🔗 doi.org/10.1016/j.cgh.…

#Gitwitter #ALD #ACLF
Reported by
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Proud to see the outcomes of the Global Think-tank on Steatotic Liver Disease 2025 meeting in Barcelona featured in The Lancet! Our multidisciplinary group tackled barriers to #MASLD diagnosis & care, with a spotlight on the urgent metabolic health threats. The story highlights

Proud to see the outcomes of the Global Think-tank on Steatotic Liver Disease 2025 meeting in Barcelona featured in <a href="/TheLancet/">The Lancet</a>! Our multidisciplinary group tackled barriers to #MASLD diagnosis &amp; care, with a spotlight on the urgent metabolic health threats. The story highlights
Jeffrey V. Lazarus (@jvlazarus) 's Twitter Profile Photo

From Barcelona to the World: Global Think‑tank on Liver Disease Makes Headlines and Enters the Scientific Record sldthinktank.com/news/global-th… #SLDthinktank #LiverTwitter

From Barcelona to the World: Global Think‑tank on Liver Disease Makes Headlines and Enters the Scientific Record
sldthinktank.com/news/global-th…
#SLDthinktank #LiverTwitter
Dr Nipun Verma (@drnipunverma) 's Twitter Profile Photo

Proud moment 😇 To bid farewell to our ⭐️mentee Dr. Ashwin Pachaatt Vinod passing out with flying colours from DM Hepatology PGI 🎓🩺 A brilliant, dedicated & passionate Hepatologist 💪🌟 Can’t wait to see you shine at INASL ✨🙌 #Hepatology #Mentorship #Inspiration

Proud moment 😇

To bid farewell to our ⭐️mentee <a href="/pachaatt/">Dr. Ashwin Pachaatt Vinod</a> passing out with flying colours from DM <a href="/HepatologyPGI/">Hepatology PGI</a> 🎓🩺

A brilliant, dedicated &amp; passionate Hepatologist 💪🌟

Can’t wait to see you shine at <a href="/INASL_Liver/">INASL</a> ✨🙌

#Hepatology #Mentorship #Inspiration
Aleksander Krag (@aleksanderkrag) 's Twitter Profile Photo

Happy to share this RCT from GALAXY in people with ALD Out today in Nature Portfolio rdcu.be/eujFT The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

Happy to share this RCT from <a href="/LiverGALAXY/">GALAXY</a> in people with ALD 

Out today in <a href="/NaturePortfolio/">Nature Portfolio</a> 

rdcu.be/eujFT

The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial
massimo iavarone (@massimoiava) 's Twitter Profile Photo

It's been a while since I last posted on X, but I think this is a great opportunity: the EASL Education and AASLD Masterclass is a chance to learn about the latest developments in the field of #LiverX disease. Only a few days left to register! EASLnews

ARPIT SHASTRI (@arpitshastri_78) 's Twitter Profile Photo

We report a rare case of congenital intrahepatic portosystemic shunt (CIPSS-Park's type I) manifested with HE in an adult . One should suspect it in absence of clinically significant liver disease, as early identification enables timely intervention. doi.org/10.1016/j.jceh…

We report a rare case of congenital intrahepatic portosystemic shunt (CIPSS-Park's type I) manifested with HE in an adult . One should suspect it in absence of clinically significant liver disease, as early identification enables timely intervention.
doi.org/10.1016/j.jceh…